MCID: SCK001
MIFTS: 39

Sick Building Syndrome malady

Category: Respiratory diseases

Aliases & Classifications for Sick Building Syndrome

About this section

Aliases & Descriptions for Sick Building Syndrome:

Name: Sick Building Syndrome 11 13 2 37 66

Classifications:



External Ids:

Disease Ontology11 DOID:2710
SNOMED-CT60 19076009
MeSH37 D018877

Summaries for Sick Building Syndrome

About this section
CDC:2 Indoor environmental quality (IEQ) refers to the quality of a building’s environment in relation to the health and wellbeing of those who occupy space within it. IEQ is determined by many factors, including lighting, air quality, and damp conditions. Workers are often concerned that they have symptoms or health conditions from exposures to contaminants in the buildings where they work. One reason for this concern is that their symptoms often get better when they are not in the building. While research has shown that some respiratory symptoms and illnesses can be associated with damp buildings, it is still unclear what measurements of indoor contaminants show that workers are at risk for disease. In most instances where a worker and his or her physician suspect that the building environment is causing a specific health condition, the information available from medical tests and tests of the environment is not sufficient to establish which contaminants are responsible. Despite uncertainty about what to measure and how to interpret what is measured, research shows that building-related symptoms are associated with building characteristics, including dampness, cleanliness, and ventilation characteristics.

MalaCards based summary: Sick Building Syndrome is related to macular degeneration, age-related, 6 and hidradenocarcinoma. An important gene associated with Sick Building Syndrome is PNPLA6 (Patatin Like Phospholipase Domain Containing 6), and among its related pathways are Adipocytokine signaling pathway and HIF-1-alpha transcription factor network. Affiliated tissues include testes, eye and bone, and related mouse phenotypes are liver/biliary system and neoplasm.

Disease Ontology:11 An extrinsic allergic alveolitis that is characterized by a set of symptoms such as headache, fatigue, eye irritation, and breathing difficulties that affect workers in modern airtight office buildings. the disease is caused by indoor pollutants (as formaldehyde fumes, particulate matter, or microorganisms), and the symptoms tend to disappear when affected individuals leave the building.

Wikipedia:69 Sick building syndrome (SBS) is used to describe situations in which building occupants experience acute... more...

Related Diseases for Sick Building Syndrome

About this section

Diseases related to Sick Building Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 62)
idRelated DiseaseScoreTop Affiliating Genes
1macular degeneration, age-related, 610.5PNPLA6, POMC
2hidradenocarcinoma10.4LEP, POMC
3patellofemoral pain syndrome10.4LEP, POMC
4laryngeal carcinoma10.4LEP, POMC
5keratoacanthoma10.4LEP, POMC
6lymphosarcoma10.3LEP, POMC
7mucolipidoses10.3LEP, POMC
8benign paroxysmal positional nystagmus10.3LEP, POMC
9chronic myelomonocytic leukemia10.3LEP, POMC
10benign eccrine breast spiradenoma10.3POMC, VEGFA
11alveoli adenoma10.2LEP, POMC
12angiomatous meningioma10.2LEP, POMC
13morphine dependence10.2POMC, VEGFA
14lateral sclerosis10.2POMC, VEGFA
15apocrine adenoma10.2LEP, VEGFA
16femoral neuropathy10.2LEP, POMC
17bladder urachal carcinoma10.2MMP9, VEGFA
18emphysematous cholecystitis10.1MMP9, VEGFA
19seminal vesicle tumor10.1MMP9, VEGFA
20intestinal benign neoplasm10.1MMP9, VEGFA
21marchiafava bignami disease10.1MMP9, VEGFA
22adenosine monophosphate deaminase 1 deficiency10.1MMP9, VEGFA
23pauciarticular onset juvenile idiopathic arthritis10.1MMP9, VEGFA
24chorioretinitis10.1MMP9, VEGFA
25histidine metabolism disease10.1MMP9, VEGFA
26preeclampsia/eclampsia 110.1LEP, VEGFA
27mantle cell lymphoma10.1MMP9, VEGFA
28integumentary system cancer10.1MMP9, VEGFA
29pulmonary sarcoidosis10.1MMP9, VEGFA
30diffuse large b-cell lymphoma10.1LEP, VEGFA
31vertebral artery occlusion10.1MMP9, VEGFA
32survival motor neuron spinal muscular atrophy10.1LEP, POMC
33oral lichen planus10.1MMP9, VEGFA
34squamous cell papilloma10.1PNPLA6, VEGFA
35atrophic rhinitis10.1MMP9, VEGFA
36neuropathy, hereditary sensory and autonomic, type vi10.1MMP9, VEGFA
37lobular neoplasia10.1MMP9, VEGFA
38malignant giant cell tumor10.0MMP9, VEGFA
39atopy10.0
40multiple chemical sensitivity10.0
41chronic fatigue syndrome10.0
42chondroma10.0MMP9, VEGFA
43neuropathy, hereditary sensory, type ib10.0MMP9, VEGFA
44dysostosis9.9MMP9, VEGFA
45plasmacytoma9.9MMP9, VEGFA
46asthma9.9
47sinusitis9.9
48rhinitis9.9
49neuropathy9.9
50stachybotrys chartarum9.9

Graphical network of the top 20 diseases related to Sick Building Syndrome:



Diseases related to sick building syndrome

Symptoms for Sick Building Syndrome

About this section

Drugs & Therapeutics for Sick Building Syndrome

About this section

Drugs for Sick Building Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DopaminePhase 3367851-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
2
SerotoninPhase 3351050-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
3
Lurasidone hydrochloridePhase 357367514-87-2213046
Synonyms:
367514-88-3
441351-20-8
D04820
Lurasidone HCl
Lurasidone hydrochloride
 
Lurasidone hydrochloride (USAN)
MK-3756
N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide
SM 13496
SM-13496
SMP-13496
4lenograstimPhase 11178
5
DexamethasonePhase 1200150-02-25743
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
137098-19-2
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16α-Methyl-9α-fluoro-1-dehydrocortisol
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-fluoro-16alpha-methyl-Prednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
AI3-50934
Adexone
Aeroseb-D
Aeroseb-Dex
Aeroseb-dex
Ak Dex Oph Otic Soln 0.1%
Alcon Brand of Dexamethasone
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (Veterinary)
Azium (veterinary)
BIDD:ER0494
BIDD:PXR0060
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
Bisu DS
Bisu Ds
C15643
C22H29FO5
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
CPD-10549
CPD001227192
Calonat
Corson
Corsone
Cortisumman
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
DEX
DEXA
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
DXM
DXMS
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-LA
Decadron-La
Decagel
Decaject
Decaject L.A.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [DCIT]
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
Dex-Ide
Dex-ide
Dexa
Dexa Mamallet
Dexa mamallet
Dexa-Cortidelt
Dexa-Cortisyl
Dexa-Mamallet
Dexa-Scheroson
Dexa-Sine
Dexa-cortidelt
Dexa-cortisyl
Dexa-scheroson
Dexa-sine
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexacortin
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
 
Dexameth
Dexamethansone
Dexamethasone
Dexamethasone (JP15/USP/INN)
Dexamethasone Acetate
Dexamethasone Alcohol
Dexamethasone Base
Dexamethasone Intensol
Dexamethasone Sodium Phosphate
Dexamethasone [INN:BAN:JAN]
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexason
Dexasone
Dexasone 0.5mg
Dexasone 0.75mg
Dexasone 4mg
Dexasporin
Dexinolon
Dexinoral
Dexone
Dexone 0.5
Dexone 0.75
Dexone 1.5
Dexone 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
Dxms
ECR Brand of Dexamethasone
EINECS 200-003-9
FT-0080377
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy Brand of Dexamethasone
Gammacorten
HL-dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
Hexadecadrol
Hexadrol
Hexadrol Elixir
Hexadrol Tablets
Hexadrol elixir
Hl-Dex
Hl-dex
I06-1196
ICN Brand of Dexamethasone
IontoDex
Isopto-Dex
Isopto-dex
LS-7300
Lokalison F
Lokalison f
Loverine
Luxazone
MK 125
MLS001055412
MLS001332507
MLS001332508
Maxidex
Maxidex Ont 0.1%
Maxidex Sus 0.1%
Maxitrol
Mediamethasone
Merck Brand of Dexamethasone
Merz Brand 1 of Dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MolMap_000018
MolPort-003-846-433
Mymethasone
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
NCI60_003067
NSC 34521
NSC34521
Naquasone (veterinary)
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
OTO-104
Ocu-Trol
Ocu-trol
Oradexon
PHL-dexamethasone
PMS-dexamethasone
Pet Derm III
Pet Derm Iii
Pet derm III
Pet-Derm Iii
Pms Dexamethasone Elixir 0.5mg/5ml
Policort
Posurdex
Prednisolon F
Prednisolon f
Prednisolone F
Prednisolone f
Prodex
S1322_Selleck
SAM002548948
SGCUT00126
SK-Dexamethasone
SK-dexamethasone
SMP1_000092
SMR000857119
SMR001227192
ST50307091
Sandoz dexamethasone
Sk-Dexamethasone
Spectrum5_002019
Spoloven
Sunia Sol D
Sunia sol D
Superprednol
TL8003317
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
alpha -Fluoro-16-alpha -methylcortisol
delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
dexamethasone
nchembio809-comp2
to_000038
6Dexamethasone acetatePhase 120011177-87-3
7
Tipranavir74174484-41-465027
Synonyms:
174484-41-4
1d4y
2o4l
2o4n
2o4p
AC1L22FH
AC1Q4JPW
Aptivus
Aptivus (Boehringer Ingelheim)
Aptivus (TN)
Aptivus(TM)
CHEMBL222559
CID65027
 
D08605
DB00932
MolPort-003-850-561
N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE
N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide
PNU 140690
PNU-140690
PNU-140690E
TPV
Tipranavir
Tipranavir (INN)
U 140690
U-140690
UNII-ZZT404XD09
tipranavir
8
Ritonavir856155213-67-5392622
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
538, ABT
A-84538
ABBOTT-84538
ABT 538
ABT 84538
ABT-538
ABT538
AC-733
AC1L94GB
AKOS000280930
Abbott 84538
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
 
DB00503
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
NSC693184
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
RIT
RTV
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
ritonavir

Interventional clinical trials:

idNameStatusNCT IDPhase
1A Twelve Week, Open Label Extension Study in Patients With SchizophreniaCompletedNCT01566162Phase 3
2PEARL Schizophrenia MaintenanceCompletedNCT01435928Phase 3
3An Integrated Program for the Treatment of First Episode of PsychosisActive, not recruitingNCT01321177Phase 2, Phase 3
4HIV Prevention With the Mentally IllCompletedNCT00643305Phase 2
5Improved Methods of Cell Selection for Bone Marrow Transplant AlternativesRecruitingNCT00001529Phase 1
6Texting to Improve Adherence in HIV+ With Bipolar DisorderCompletedNCT02090634
7Literacy-Adapted Psychosocial Treatments for Chronic Pain --- "Learning About Mastering/My Pain"Active, not recruitingNCT01967342
8Serum Auto-AntibodiesActive, not recruitingNCT00704626
9Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV InfectionNo longer availableNCT00062660

Search NIH Clinical Center for Sick Building Syndrome


Cochrane evidence based reviews: sick building syndrome

Genetic Tests for Sick Building Syndrome

About this section

Anatomical Context for Sick Building Syndrome

About this section

MalaCards organs/tissues related to Sick Building Syndrome:

34
Testes, Eye, Bone, Bone marrow, Endothelial, Colon

Animal Models for Sick Building Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Sick Building Syndrome:

39 (show all 13)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053709.0LEP, LRP6, POMC, VEGFA
2MP:00020068.9LEP, MMP9, POMC, VEGFA
3MP:00053888.8LEP, LRP6, MMP9, VEGFA
4MP:00053718.5LEP, LRP6, MMP9, VEGFA
5MP:00053858.3LEP, MMP9, PNPLA6, POMC, VEGFA
6MP:00053678.2LEP, LRP6, MMP9, POMC, VEGFA
7MP:00107718.1LEP, LRP6, MMP9, PNPLA6, POMC, VEGFA
8MP:00053848.0LEP, LRP6, MMP9, PNPLA6, POMC, VEGFA
9MP:00053787.8LEP, LRP6, MMP9, PNPLA6, POMC, VEGFA
10MP:00053767.7LEP, LRP6, MMP9, PNPLA6, POMC, VEGFA
11MP:00036317.0ITM2B, LEP, LRP6, MMP9, PNPLA6, POMC
12MP:00053866.9ITM2B, LEP, LRP6, MMP9, PNPLA6, POMC

Publications for Sick Building Syndrome

About this section

Articles related to Sick Building Syndrome:

(show top 50)    (show all 205)
idTitleAuthorsYear
1
Endotoxin, ergosterol, muramic acid and fungal DNA in dust from schools in Johor Bahru, Malaysia--Associations with rhinitis and sick building syndrome (SBS) in junior high school students. (26745297)
2016
2
A Longitudinal Study of Sick Building Syndrome (SBS) among Pupils in Relation to SO2, NO2, O3 and PM10 in Schools in China. (25398002)
2014
3
Sick building syndrome by indoor air pollution in Dalian, China. (23579877)
2013
4
Sick building syndrome in a general hospital and the risks for pregnant workers. (21458809)
2011
5
Sick Building Syndrome and autoimmunity. (21300685)
2011
6
An update on sick building syndrome. (19532093)
2009
7
The sick building syndrome. (20040980)
2008
8
Case study of volatile organic compounds in indoor air of a house before and after repair where sick building syndrome occurred. (17903361)
2007
9
Serum levels of volatile organic compounds in patients with sick building syndrome. (17033858)
2006
10
Personal and psychosocial factors and symptoms compatible with sick building syndrome in the Swedish workforce. (17100665)
2006
11
Adaptation of office workers to a new building - impaired well-being as part of the sick-building-syndrome. (16697700)
2006
12
Associations among sick building syndrome, psychosocial factors, and personality traits. (16060437)
2005
13
Fungal contamination as a major contributor to sick building syndrome. (15350790)
2004
14
The role of stachybotrys in the phenomenon known as sick building syndrome. (15350793)
2004
15
Sick building syndrome in like symptoms in emergency prefabricated accommodation. (15345200)
2004
16
Multiple logistic regression modelling substantiates multifactor contributions associated with sick building syndrome in residential interiors in Mauritius. (12745349)
2003
17
Studies on the role of fungi in Sick Building Syndrome. (15259426)
2003
18
The sick building syndrome: what is it when it is? (12085462)
2002
19
The full circle: from the Minamata disaster to the sick building syndrome. (11564629)
2001
20
Possible sources of sick building syndrome in a Tennessee middle school. (11777022)
2001
21
Rebuttal to letter of John H Keene concerning our 15(10) 2000 article "resolution of sick building syndrome in a high-security facility". (11297049)
2001
22
The effects of outdoor air supply rate in an office on perceived air quality, sick building syndrome (SBS) symptoms and productivity. (11089327)
2000
23
Sick building syndrome. Indoor air quality and your patients' health. (11521615)
2000
24
Relationships between occupant personality and the sick building syndrome explored. (10979197)
2000
25
Rx for SBS. Suspect sick building syndrome? Get a diagnosis from the experts. (16646168)
2000
26
The sick building syndrome. (10598396)
1999
27
Sick-building syndrome. (9235451)
1997
28
Indoor air pollutants and sick building syndrome: a case study and implications for the community health nurse. (9078851)
1997
29
Indoor pollution and sick building syndrome symptoms among workers in day-care centers. (9169630)
1997
30
The natural history of concurrent sick building syndrome and chronic fatigue syndrome. (9201647)
1997
31
New and emerging pathogens, Part 6. Sick-building syndrome and building-related illness. (10162473)
1996
32
Sick-building syndrome in a tropical city. (8622382)
1996
33
Sick building syndrome. (8637130)
1996
34
Sick building syndrome and gender bias: imperiling women's health. (7747241)
1995
35
Ventilation rate in office buildings and sick building syndrome. (8535489)
1995
36
The Sick Building Syndrome (SBS) in office workers. A case-referent study of personal, psychosocial and building-related risk indicators. (7721522)
1994
37
Building and Home-Related Complaints and Illnesses: Sick Building Syndrome. Conference proceedings. Lake Buena Vista, Florida, December 3-5, 1992. (7915735)
1994
38
Town planning & health. Sick building syndrome. (10135739)
1994
39
Building components contributors of the sick building syndrome. (8175632)
1994
40
Patients and the sick building syndrome. (8077587)
1994
41
Concurrent sick building syndrome and chronic fatigue syndrome: epidemic neuromyasthenia revisited. (8148452)
1994
42
Sick building syndrome--know your ventilation rates. (10126689)
1993
43
Field studies on the sick building syndrome. (1580471)
1992
44
Sick building syndrome. Medical evaluation of two work forces. (1464788)
1992
45
Sick building syndrome. (1683923)
1991
46
Sick-building syndrome. (1821387)
1991
47
Sick building syndrome. (1986430)
1991
48
Influence of indoor climate on the sick building syndrome in an office environment. The Danish Indoor Climate Study Group. (2255877)
1990
49
Allergic investigations in patients with the sick building syndrome. (2401142)
1990
50
The sick building syndrome. (3917804)
1985

Variations for Sick Building Syndrome

About this section

Expression for genes affiliated with Sick Building Syndrome

About this section
Search GEO for disease gene expression data for Sick Building Syndrome.

Pathways for genes affiliated with Sick Building Syndrome

About this section

GO Terms for genes affiliated with Sick Building Syndrome

About this section

Cellular components related to Sick Building Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00056157.6ITM2B, LEP, MMP9, POMC, VEGFA
2extracellular regionGO:00055766.8ITM2B, LEP, LRP6, MMP9, POMC, VEGFA

Biological processes related to Sick Building Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of p38MAPK cascadeGO:19007459.8LEP, VEGFA
2positive regulation of tyrosine phosphorylation of Stat3 proteinGO:00425179.7LEP, VEGFA
3macrophage differentiationGO:00302259.6MMP9, VEGFA
4regulation of blood pressureGO:00082179.3LEP, POMC
5dopaminergic neuron differentiationGO:00715429.2LRP6, VEGFA
6angiogenesisGO:00015259.0LEP, PNPLA6, VEGFA

Molecular functions related to Sick Building Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1receptor bindingGO:00051029.1LEP, LRP6, POMC

Sources for Sick Building Syndrome

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet